Cure for baldness will not be available on NHS
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.The anti-baldness cure Propecia will not be available on the National Health Service when it is launched in the United Kingdom next year.
The anti-baldness cure Propecia will not be available on the National Health Service when it is launched in the United Kingdom next year.
The Government has agreed to a request from the manufacturers, Merck Sharpe and Dohme, that it be put on the blacklist of drugs that GPs cannot prescribe on the NHS. The move follows the ruling earlier this year that Viagra can only be prescribed to men with certain conditions on the NHS and that all others must obtain it privately.
Merck Sharpe and Dohme has said it would be "inappropriate" for the drug to be made available on the NHS when it ws not paid for by the health service in any of the 38 countries where it already has licences.
An estimated 800,000 men around the world are said to be using Propecia, which is expected to cost around £25 for a month's supply in Britain. Its active ingredient - finasteride - is already available here, as Prosca, to treat enlarged prostate glands. It was men being treated for prostate problems who first reported its welcome side-effect.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments